0001567619-21-016025.txt : 20210818
0001567619-21-016025.hdr.sgml : 20210818
20210818071131
ACCESSION NUMBER: 0001567619-21-016025
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20210818
DATE AS OF CHANGE: 20210818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Chad Thomas
CENTRAL INDEX KEY: 0001706852
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 211185002
MAIL ADDRESS:
STREET 1: 140 POKANOKET PATH
CITY: WRENTHAM
STATE: MA
ZIP: 02093
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2021-08-12
2021-08-17
0
0001275187
ANGIODYNAMICS INC
ANGO
0001706852
Campbell Chad Thomas
14 PLAZA DRIVE
LATHAM
NY
12110
0
1
0
0
SVP/GM, Vascular Access
Common Stock
2021-08-12
4
M
0
8210
0
A
34871
D
Common Stock
2021-08-12
4
F
0
3130
27.29
D
31741
D
Performance Right
2021-08-12
4
M
0
7079
0
D
Common Stock
7079
0
D
On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold.
This acquisition of 8,210 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018.
The exempt disposition of 3,130 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018.
On July 18, 2018, the reporting person received a target grant of 7,079 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 8,210 shares of Common Stock were issued to the reporting person under this grant.
/s/ Richard C. Rosenzweig, Attorney in Fact
2021-08-17